Mainstream

Exelixis Targets $5b Zanza Sales By 2033 With Multiple Pivotal Trials In Progress

Exelixis targets $5B Zanza sales by 2033 with multiple pivotal trials in progress

Exelixis targets $5B Zanza sales by 2033 with multiple pivotal trials in progress

Post ContentexelRead More

You might also be interested in reading BlackRock’s IBIT powers new bitcoin annuity for U.S. retirees via Delaware Life.

February 12, 2025
In Mainstream